Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High-energy visible light blocking refers to optical filtration or material-based strategies—such as specially designed glasses, lens coatings, or cosmetic agents—that aim to absorb, reflect, or filter out the short-wavelength, high-energy blue/violet light (generally 400–455 nm) from reaching biological tissues like the **retina** or **skin**[4][5][7]. The rationale is to reduce or prevent the **photochemical and oxidative damage** associated with excessive HEV light exposure, which, according to experimental and epidemiological data, is implicated in processes like retinal cell damage, accelerated photoaging, and possibly age-related macular degeneration[4][5][6]. The concept of "blocking high-energy visible light" is not associated with a single biomolecule, protein, or defined biological target, but rather encompasses a class of physical or material interventions that modulate light penetration to tissues. In summary, "high-energy visible light blocking" is **not a canonical molecular target** but rather an attribute or function of materials and products designed to offer **photoprotection**—most notably for use in eyewear and topical products for skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High-energy visible light blocking.